2Q21 Zeposia sales were $28M (up from $18M in 1Q21). I was expecting a steeper ramp given that 2Q21 was more than one year since FDA approval. What about you?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”